Psyche, Soma & Spirit

The Common Biochemical Signatures Beneath Autism, ADHD, and Anxiety

By Julie Matthews, MS, Contributing Writer

One patient arrives with an autism diagnosis, another with ADHD, a third with anxiety. On paper, three separate conditions. But order the right labs and the same patterns turn up: low zinc, elevated copper, sluggish methylation, signs of oxidative stress. Outwardly, the diagnoses differ. The underlying biochemistry often doesn’t. These three diagnoses that present quite […]

Pistachio-Derived Melatonin Improves Sleep Quality

By Janet Gulland, Contributing Writer

Pistachio nuts are a rich source of naturally-occurring melatonin, and Australian researchers have shown that supplementation with pistachio-derived melatonin is equally effective in improving sleep parameters, as more the widely available synthetic forms of melatonin. Some cultivars of pistachio (Pistacia vera, Anacardiaceae) naturally produce as much as 223 µg/g of phytomelatonin. That fact prompted Network […]

A New Clinical Tool to Assess “Food Noise”

By Janet Gulland, Staff Writer

Food noise—the relentless, intrusive, uncontrollable mental rumination about food—is a common experience reported by people struggling to manage their weight. The surge in use of GLP-1 inhibiting drugs has spotlighted this phenomenon because many patients report that GLP-1 treatments quell the intensity of food-related thoughts. But until recently, clinicians and researchers have been at a […]

For Depression, Transcranial Magnetic Stimulation Shouldn’t Just Be a Last Resort

By Michael C. Marone

(This article was originally pubished on Dec. 11, 2025, on Undark) For decades, the treatment of clinical depression has followed the same outdated flow chart: Try one antidepressant, then another, then a combination, then maybe just one more. Finally, when all pharmaceutical attempts fail, consider other approaches. This protocol, called step therapy, has come under […]

To Help Patients Sleep, Ask the Right Questions

By Ron Grisanti, DC, Contributing Writer

Conventional medicine tends to view insomnia as an isolated problem — a nuisance symptom to be ameliorated. The solutions offered usually fall into three categories: Basic sleep hygiene advice: Recommendations like reducing screen time, keeping the bedroom dark, or sticking to a bedtime routine are helpful, but they are rarely enough on their own. For […]

Noise: Not Just a Nuisance, It’s a Public Health Risk

By Erik Goldman

Back at the turn of the 20th Century, physician-bacteriologist Robert Koch predicted that, “One day, man will have to fight noise as fiercely as cholera and the plague.” That day is definitely upon us. The detrimental impact of noise goes far beyond the obvious problem of hearing loss. Over the last decades, researchers have shown, […]

Exploring a Plant-Based Alternative for Better Rest

By Suresh Lakshmikanthan, PhD., B.Pharm

There are many herbs and nutraceuticals that can help improve sleep quality. Certainly, your patients are aware of these, and many are experimenting with them, in their quest for better sleep. But it is essential to understand the biological foundations of sleep in order to know how herbs and nutraceuticals can optimize the quantity and […]

In Memoriam: Col. Richard Niemtzow, Medical Acupuncture Trailblazer

By Erik Goldman

A few decades ago, acupuncture was not a modality one expected US military healthcare to embrace. For most non-Asian Americans, it was more the stuff of myth than a reality of medical practice. Colonel Richard Charles Niemtzow, MD, PhD, MPH, did much to change that. Over his long and admirable career, he worked tirelessly to […]

This Time, Five Years Ago…

By Erik Goldman

It was right about this time, five years ago. I woke up one morning with a raunchy cough, a head full of mucus, and an aching body that felt like a sack of potatoes. “This is weird,” I thought. I seldom get sick, and when I do it’s usually in the November-to-December transition when temperatures […]

How the FDA Could Shape the Future of Psychedelics Research

By Joshua Cohen

(Originally published by www.undark.org, Aug 5, 2024) In August, the US Food and Drug Administration decided not to approve the psychedelic drug MDMA (midomafetamine) for use in patients with post-traumatic stress disorder in conjunction with psychological intervention. The move signals the FDA’s desire to put the brakes on the psychedelics research, which has rapidly  moved […]